`
Founded by pioneering scientists, Prana Therapeutics brings you the the highest quality polymolecular botanical formulations with results backed by science & testimonials from our customers
The vast majority of diseases are driven by multiple factors, yet the vast majority of drug trials use single agents targeting a single contributing mechanism of the disease. Prana Therapeutics’ Polymolecular Botanical Drug development platform addresses these deficiencies by simultaneously targeting multiple mechanisms and de-risking clinical trials.

Our Mission & Vision
At Prana Therapeutics, our mission is to enhance the quality of life for individuals suffering from inflammatory conditions through our Poly-Molecular Botanical supplement EDP (Epidiferphane). We believe in the power of nature and science working together to promote health and wellness.
Our vision is to become a leading name in health supplements by offering innovative, natural solutions that are both effective and safe. We aim to empower our customers with better joint health, enhanced recovery, and improved cognitive function.

Dr. Brent Reynolds PHD DCM
Professor Reynolds holds 16 US patents related to neural stem cells and his lab is currently focused on the development of stem cell specific assays, in situ manipulation of neural stem cells and understanding the role that solid tissue cancer stem cells play in tumor initiation and metastasis.
Name Lastname


Name Lastname


Give your list item a title
Give your list item a title
Tell your story in numbers, and give your visitors useful insights.
Make an impact, and share your organization’s stats or achievements to interest your website visitors into learning more about you.
Stat title
Stat title
Stat title
Our Mission and Vision
At Prana Therapeutics, our mission is to enhance the quality of life for individuals suffering from inflammatory conditions through our Poly-Molecular Botanical supplement EDP (Epidiferphane). We believe in the power of nature and science working together to promote health and wellness.
Our vision is to become a leading name in health supplements by offering innovative, natural solutions that are both effective and safe. We aim to empower our customers with better joint health, enhanced recovery, and improved cognitive function.
Our Journey
Prana Therapeutics was founded out of a passion for natural remedies and a desire to offer an alternative to traditional anti-inflammatory treatments. Our founders, with backgrounds in health and wellness, sought to create a product that would harness the therapeutic benefits of natural ingredients like curcumin, EGCG, and sulforaphane.
Joint Health and Mobility
Prana Therapeutics’ supplement is crafted with a unique blend of natural ingredients specifically targeting joint health. The special form of curcumin from turmeric has been shown to reduce inflammation and pain in joints, making it an ideal ally for those suffering from rheumatoid arthritis and general joint pain.
Through rigorous research and development, we have crafted a supplement that not only targets joint health and athletic recovery but also supports mental clarity. Our commitment to quality and efficacy is unwavering as we continue to explore the potentials of nature in health and healing.
Our Approach
The vast majority of diseases are driven by multiple factors, yet the vast majority of drug trials use single agents targeting a single contributing mechanism of the disease. Prana Therapeutics’ Polymolecular Botanical Drug development platform addresses these deficiencies by simultaneously targeting multiple mechanisms and de-risking clinical trials.
PolyMolecular Botanical Compounds
Using disease-specific screens, we have identified unique combinations of botanical extracts that target the multiple contributing mechanisms of disease initiation and progression. Our lead compounds, including Epidiferphane, have demonstrated strong preclinical efficacy at preventing and treating several disease indications.

Brent Reynolds, PhD
Prana Therapeutics Founder, Brent A. Reynolds, PhD, received his Ph.D. in 1994 from the University of Calgary during which time he and Sam Weiss discovered the existence of a stem cell in the adult central nervous system, challenging a century old dogma that the adult brain was unable to produce new neurons. He co-founded NeuroSpheres Ltd. where he was Vice-President of Research and in 1999 published the first report on the trans-differentiation of cells derived from one germ layer into functional cells of another germ layer.
Professor Reynolds holds 16 US patents related to neural stem cells and his lab is currently focused on the development of stem cell specific assays, in situ manipulation of neural stem cells and understanding the role that solid tissue cancer stem cells play in tumor initiation and metastasis.
Heshan “Grasshopper” Illangkoon, PhD
Ogawa Kazumasa
